Trials / Conditions / Hypopharynx Cancer

Hypopharynx Cancer

21 registered clinical trials studyying Hypopharynx Cancer — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Canc NCT07063212	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma NCT06706401	Centre Leon Berard	Phase 3
Recruiting	SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Pat NCT06611137	Sun Yat-sen University	Phase 2
Not Yet Recruiting	Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngea NCT06554028	Henan Cancer Hospital	Phase 2
Withdrawn	A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor NCT04892875	Jennifer Choe	Phase 1
Active Not Recruiting	The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors NCT05798780	H. Lee Moffitt Cancer Center and Research Institute	N/A
Unknown	Immunological Function After Radiation With Either Proton or Photon Therapy NCT06016699	University Medical Center Groningen	—
Recruiting	Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy NCT05337631	University Hospital Freiburg	—
Unknown	Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinom NCT04995120	Fudan University	Phase 2
Completed	Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinom NCT03082534	University of California, San Diego	Phase 2
Completed	Adaptive Radiotherapy for Head and Neck Cancer NCT03096808	Memorial Sloan Kettering Cancer Center	Phase 2
Unknown	Cell-free Tumor DNA in Head and Neck Cancer Patients NCT03942380	Christian von Buchwald	N/A
Unknown	A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients NCT03039465	HealthCare Global Enterprise Ltd.	N/A
Completed	Pembrolizumab in Combination With CRT for LA-SCCHN NCT02586207	Sanford Health	Phase 1
Terminated	Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cance NCT01066741	Centre Leon Berard	Phase 3
Completed	Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preserv NCT00169247	Groupe Oncologie Radiotherapie Tete et Cou	Phase 2
Completed	IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC NCT00158678	Groupe Oncologie Radiotherapie Tete et Cou	Phase 3
Completed	Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Car NCT00169182	Groupe Oncologie Radiotherapie Tete et Cou	Phase 3
Completed	Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC NCT00158652	Groupe Oncologie Radiotherapie Tete et Cou	Phase 3
Completed	Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC NCT00162708	Gustave Roussy, Cancer Campus, Grand Paris	Phase 2 / Phase 3
Terminated	Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cance NCT00080028	Pharmacyclics LLC.	Phase 1